Loading...

NK Cell Cancer Immunotherapy

The concept of adoptive NK cell cancer immunotherapy to fight cancer was proven a decade ago from pioneering clinical studies against hematological malignancies.

Many efforts are emerging for developing and engineering NK cell-based cancer immunotherapy.

Because of their ability to kill tumor cells, NK cells are an attractive target for cancer immunotherapies. We want to use the best that nature and the human immune system have to offer . For this, NK cells are a very logical candidate. They are considered safer than T cells, and can be offered off-the-shelf and are available to patients as soon as they are needed.

Please watch the video below to find out more about NK Cells Cancer Immunotherapy

Natural killer cells Treatment (also known as NK cells, K cells, and killer cells) are a type of lymphocyte (a white blood cell) and a component of innate immune system.

Natural killer (NK) cells are a type of lymphoid cell which function in the innate immune system to remove infected or cancerous self-cells. NK cells play a major role in the host-rejection of both tumours and virally infected cells.

Advantages of using NK Cells for cancer immunotherapy include:

1. safer than car-t cells treatments because it has a wider range of ways to target tumor cells
2. no risk of rejection due to autologous application (i.e. extraction from your own immune cells)
3. can be used concurrently with other cancer treatments to produce maximum results.

The treatment of NK cells for cancer immunotherapy should be advised a certified immunologist to produce the best results.

For more information, you can whatsapp us at +6010-838-9254 to request for your FREE Consultation today.

Discover true freedom through cell rejuvenation

We are here for you. Let us answer any queries you have relating to cell Rejuvenation Products and Stem Cell therapy technologies or our aesthetic & anti aging treatments

For more information, you can click here to whatsapp us at +6010-838-9254 to request for your FREE Consultation today.